Hong Kong-based IntelliGen AI unveiled its new AI protein structure prediction platform called IntFold on July 12, 2025, specifically designed to compete with Google DeepMind's AlphaFold 3 model in the field of drug discovery. IntFold, the company's flagship product, has achieved 98.7% accuracy in predicting